Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Hirakawa

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Japanese Journal of Clinical Oncology|September 29, 2016
Quality of life and functional status of terminally ill head and neck cancer patients: a nation-wide, prospective observational study at tertiary cancer centers in JapanTakeshi Shinozaki, Mitsuru Ebihara, Satoru Iwase, et al.
Microorganisms|April 3, 2021
Coordinated Expression of HPV-6 Genes with Predominant E4 and E5 Expression in Laryngeal PapillomaTaro Ikegami, Hitoshi Hirakawa, Narutoshi Tsukahara, et al.
Auris, Nasus, Larynx|August 7, 2016
Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trialKouki Miura, Hitoshi Hirakawa, Hirokazu Uemura, et al.
Auris, Nasus, Larynx|December 13, 2021
Distribution pattern and pathologic analysis of metastatic sentinel and non-sentinel lymph nodes in lymphatic basin dissection for clinical T2/T3 oral cancer with clinical N0 statusHitoshi Hirakawa, Takashi Matsuzuka, Hirokazu Uemura, et al.
BMC Cancer|January 23, 2021
Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinomaShunsuke Kondo, Hitoshi Hirakawa, Taro Ikegami, et al.
Journal of Clinical Medicine|November 14, 2023
p16 Overexpression in Sinonasal Squamous Cell Carcinoma: Association with Human Papillomavirus and Prediction of Survival OutcomesHitoshi Hirakawa, Taro Ikegami, Masatomo Touyama, et al.
International Journal of Clinical Oncology|February 16, 2023
Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancerTakahito Kondo, Kiyoaki Tsukahara, Daisuke Kawakita, et al.
Scientific Reports|April 15, 2023
Predictive factors for dissection-free sentinel node micrometastases in early oral squamous cell carcinomaTakashi Matsuzuka, Kiyoaki Tsukahara, Seiichi Yoshimoto, et al.
International Journal of Clinical Oncology|February 9, 2026
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)Motoyuki Suzuki, Akehito Kishino, Masashi Sugasawa, et al.
International Journal of Clinical Oncology|November 13, 2021
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world studyRyuji Yasumatsu, Yasushi Shimizu, Nobuhiro Hanai, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Japanese Journal of Clinical Oncology|September 29, 2016
Quality of life and functional status of terminally ill head and neck cancer patients: a nation-wide, prospective observational study at tertiary cancer centers in JapanTakeshi Shinozaki, Mitsuru Ebihara, Satoru Iwase, et al.
Microorganisms|April 3, 2021
Coordinated Expression of HPV-6 Genes with Predominant E4 and E5 Expression in Laryngeal PapillomaTaro Ikegami, Hitoshi Hirakawa, Narutoshi Tsukahara, et al.
Auris, Nasus, Larynx|August 7, 2016
Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trialKouki Miura, Hitoshi Hirakawa, Hirokazu Uemura, et al.
Auris, Nasus, Larynx|December 13, 2021
Distribution pattern and pathologic analysis of metastatic sentinel and non-sentinel lymph nodes in lymphatic basin dissection for clinical T2/T3 oral cancer with clinical N0 statusHitoshi Hirakawa, Takashi Matsuzuka, Hirokazu Uemura, et al.
BMC Cancer|January 23, 2021
Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinomaShunsuke Kondo, Hitoshi Hirakawa, Taro Ikegami, et al.
Journal of Clinical Medicine|November 14, 2023
p16 Overexpression in Sinonasal Squamous Cell Carcinoma: Association with Human Papillomavirus and Prediction of Survival OutcomesHitoshi Hirakawa, Taro Ikegami, Masatomo Touyama, et al.
International Journal of Clinical Oncology|February 16, 2023
Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancerTakahito Kondo, Kiyoaki Tsukahara, Daisuke Kawakita, et al.
Scientific Reports|April 15, 2023
Predictive factors for dissection-free sentinel node micrometastases in early oral squamous cell carcinomaTakashi Matsuzuka, Kiyoaki Tsukahara, Seiichi Yoshimoto, et al.
International Journal of Clinical Oncology|February 9, 2026
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study)Motoyuki Suzuki, Akehito Kishino, Masashi Sugasawa, et al.
International Journal of Clinical Oncology|November 13, 2021
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world studyRyuji Yasumatsu, Yasushi Shimizu, Nobuhiro Hanai, et al.
Pageof 9